Skip to main content

Table 1 Characteristics of eligible patients

From: Successful adjuvant bi-weekly gemcitabine chemotherapy for pancreatic cancer without impairing patients’ quality of life

  Group A (n= 58)   Group B (n= 36)   P value
  Number % Number %  
Age (years)      
  Median 68   69.5   0.07
  Range 34–82   50–84   
Sex      
  Male 36 62.1 20 55.6 0.32
  Female 22 37.9 16 44.4  
Operative procedure      
  PDa 45 77.6 26 72.2 0.36
  DPb 13 22.4 10 27.8  
Primary tumor size      
  T1 3 5.2 1 2.8  
  T2 8 13.8 8 22.2 0.47
  T3 36 62.1 21 58.3  
  T4 11 19.0 6 16.7  
Nodal status      
  N0 27 46.6 15 41.7 0.45
  N1 31 53.4 21 58.3  
Resection status c      
  R0 38 65.5 22 61.1 0.49
  R1 20 34.5 14 38.9  
UICC stage d      
  I 10 17.2 7 19.4  
  II 27 46.6 15 41.7 0.38
  III 7 12.1 4 11.1  
  IV 14 24.1 10 27.8  
Histology      
  Adenocarcinoma 54 93.1 33 91.7 0.69
  Other 4 6.9 3 8.3  
  1. a Pancreatoduodenectomy, b distal pancreatectomy, c R0 or R1 means negative or positive margin microscopically, d sixth edition of International Union Against Cancer stages.